GLP-1 medications reshape spending, winning brands offer nutrition.
GLP-1 drugs—known for reducing appetite and driving weight loss—are now influencing what Americans buy, especially in food and apparel.
Food Behavior Shifts
Surveyed GLP-1 users report:
- Smaller meals (76%) and reduced fast-food consumption (62%)
- Higher purchases of high-protein and nutrient-dense foods
- Lower spend on sugary snacks and large-portion dining
- Increased interest in functional products like shakes, yogurts, and broths
Grocery Spending Patterns
Apparel Impact
As body sizes change over 6–12 months:
- 67% purchased new clothes
- Activewear purchasing increases (48%)
- Some shift out of plus-size categories
- Demand rises for adaptive fits, stretch fabrics, and versatile silhouettes
Emotional Drivers
Users report:
- Greater motivation to sustain healthy habits (72%)
- More confidence shopping for clothes
- Some overwhelm due to needing multiple wardrobes
Key Insight
GLP-1 isn’t just a health trend—it’s reshaping spending patterns. Brands that respond with functional nutrition, flexible sizing, and supportive messaging will be best positioned to win in this emerging consumer landscape.
Our Global Clients
Our data-driven insights have influenced the strategy of 200+ reputed companies across the globe.
